SCC: Not So Easy on the Eyes
No account yet? Register
Incidence of these neoplasms is related to increased age, poor skin pigmentation (pink skin around the eye), and increased ultraviolet light exposure. Appaloosas, Paints, Haflingers, and draft horse breeds (especially Belgians, Shires, and Clydesdales) are at an increased risk for developing SCC. These breeds’ characteristic coat and skin -coloring—they are often chestnuts or other coat colors with pink skin around the eyes—likely contributes to SCC’s prevalence among these horses. This does tend to be a cancer of older horses, but horses of any age can be affected. Ultraviolet light causes mutations in a tumor suppressor gene, which is why it is implicated in this condition.
Tumors involving the corneolimbal or limbal region often go unnoticed, especially in their early stages. Approximately 30% of ocular SCCs are corneolimbal in origin, most commonly involving the lateral limbus (outside the cornea) and extending to the adjacent conjunctiva and cornea. Early lesions may present as a red eye due to corneal or conjunctival hyperemia (redness). Veterinarians often diagnose these precancerous lesions via microscopic exam of a tissue sample, whereas more progressive lesions have the telltale white-to-pink appearance with raised cobblestone architecture. Less commonly, SCC invades the cornea’s deeper layers, resulting in a diffuse white to pink corneal haze. Veterinarians make definitive diagnoses using biopsy results, though limbal SCC’s unique look helps them distinguish it from other diseases.
Treatment depends on SCC location and size, extent of invasion, vision status, the horse’s purpose, treatment equipment availability, and the owner’s financial constraints. Options for treating corneolimbal SCC frequently involve surgical removal combined with a second therapeutic modality. Veterinarians select a particular complementary therapy based, again, on the equipment available and expense to the client, along with the need for general anesthesia versus sedation. They have several options to choose from to most effectively and efficiently tailor treatment to each case. -Adjunctive therapy options include cryotherapy (freezing), radiofrequency hyperthermia, β-irradiation (Sr90), CO2 laser ablation, or topical chemotherapy with mitomycin C (MMC). Long-term successful treatment or nonrecurrence rates range from 45% to 100% with the various therapies; however, veterinarians have found it necessary to use some form of adjunctive therapy following surgical excision to decrease tumor recurrence TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com. Already have an account?Create a free account with TheHorse.com to view this content.
Start your free account today!
and continue reading.
Chelsey Miller, DVM
Related Articles
Stay on top of the most recent Horse Health news with